Atlas Trials

Uterine Leiomyosarcoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Uterine Leiomyosarcoma

RecordFirmDate
CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma (NCT04727242)Stanford University2021-01-28
Combined CRS With HIPEC in Women With Inadvertently Morcellated uLMS (NCT06678763)Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University2016-01-01
Pazopanib for Treating Uterine Leiomyosarcoma (NCT02378142)Gynecologic Oncology Group2015-03-01
Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus (NCT00378911)National Cancer Institute (NCI)2006-10-01
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma (NCT00390234)National Cancer Institute (NCI)2006-09-01
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma (NCT00245102)National Cancer Institute (NCI)2005-09-01
Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus (NCT00614835)Memorial Sloan Kettering Cancer Center2001-08-01

Track Uterine Leiomyosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.